Genzyme hasn’t engaged in sham litigation in Brazil, CADE's lawyers say
Sanofi-owned Genzyme Corp. and its subsidiary Genzyme do Brasil should be acquitted in a probe accusing them of launching sham litigation to block competitors in the market for drugs that treat...To view the full article, register now.
Already a subscriber? Click here to view full article